Epinephrine Protects Cancer Cells from Apoptosis via Activation of cAMP-dependent Protein Kinase and BAD Phosphorylation*

The stress hormone epinephrine is known to elicit multiple systemic effects that include changes in cardiovascular parameters and immune responses. However, information about its direct action on cancer cells is limited. Here we provide evidence that epinephrine reduces sensitivity of cancer cells to apoptosis through interaction with β2-adrenergic receptors. The antiapoptotic mechanism of epinephrine primarily involves phosphorylation and inactivation of the proapoptotic protein BAD by cAMP-dependent protein kinase. Moreover, BAD phosphorylation was observed at epinephrine concentrations found after acute and chronic psychosocial stress. Antiapoptotic signaling by epinephrine could be one of the mechanisms by which stress promotes tumorigenesis and decreases the efficacy of anti-cancer therapies.

[1]  M. Sadar.  Androgen-independent Induction of Prostate-specific Antigen Gene Expression via Cross-talk between the Androgen Receptor and Protein Kinase A Signal Transduction Pathways* , 1999, The Journal of Biological Chemistry.

[2]  Liz Y. Han,et al.  Stress Hormone–Mediated Invasion of Ovarian Cancer Cells , 2006, Clinical Cancer Research.

[3]  P. Casey,et al.  Androgen Receptor Activation by Gs Signaling in Prostate Cancer Cells* , 2005, Journal of Biological Chemistry.

[4]  George Kulik,et al.  Epidermal Growth Factor Protects Prostate Cancer Cells from Apoptosis by Inducing BAD Phosphorylation via Redundant Signaling Pathways* , 2006, Journal of Biological Chemistry.

[5]  T. Wheeler,et al.  Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. , 2006, Cancer research.

[6]  R. Lefkowitz,et al.  Negative antagonists promote an inactive conformation of the beta 2-adrenergic receptor. , 1994, Molecular pharmacology.

[7]  A. Weeraratna,et al.  Thapsigargin induces a calmodulin/calcineurin‐dependent apoptotic cascade responsible for the death of prostatic cancer cells , 2000, The Prostate.

[8]  E. Aandahl,et al.  Localized effects of cAMP mediated by distinct routes of protein kinase A. , 2004, Physiological reviews.

[9]  S R Datta,et al.  14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. , 2000, Molecular cell.

[10]  D. McConkey,et al.  Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line. , 1996, Cancer research.

[11]  E. Ben-Josef,et al.  Humoral mechanisms in prostate cancer:: A role for FSH , 2001 .

[12]  Liz Y. Han,et al.  Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma , 2006, Nature Medicine.

[13]  B. Rabin,et al.  Psychologic stress, immunity, and cancer. , 1998, Journal of the National Cancer Institute.

[14]  J. Nelson,et al.  Endothelin-1 inhibits apoptosis in prostate cancer. , 2005, Neoplasia.

[15]  G Dhom,et al.  Relation of endocrine‐paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate , 1991, The Prostate.

[16]  Pengcheng Zhu,et al.  Psychological stress induces chemoresistance in breast cancer by upregulating mdr1. , 2005, Biochemical and biophysical research communications.

[17]  A. Wittinghofer,et al.  Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP , 1998, Nature.

[18]  Sandeep Robert Datta,et al.  Diverse Antiapoptotic Signaling Pathways Activated by Vasoactive Intestinal Polypeptide, Epidermal Growth Factor, and Phosphatidylinositol 3-Kinase in Prostate Cancer Cells Converge on BAD* , 2006, Journal of Biological Chemistry.

[19]  A. Sood,et al.  Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  N. Kyprianou,et al.  Androgen regulation of programmed death of normal and malignant prostatic cells. , 1992, Journal of andrology.

[21]  Susan S. Taylor,et al.  Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. , 1999, Molecular cell.

[22]  D. Green,et al.  A Matter of Life and Death , 2008, Science.

[23]  E. Bissonette,et al.  Activated 3′,5′-Cyclic AMP-dependent Protein Kinase Is Sufficient to Induce Neuroendocrine-like Differentiation of the LNCaP Prostate Tumor Cell Line* , 2000, The Journal of Biological Chemistry.

[24]  R. Panettieri,et al.  Cytokines regulate beta-2-adrenergic receptor responsiveness in airway smooth muscle via multiple PKA- and EP2 receptor-dependent mechanisms. , 2005, Biochemistry.

[25]  J. Nelson,et al.  The endothelin axis: emerging role in cancer , 2003, Nature Reviews Cancer.

[26]  G. Coetzee,et al.  The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus. , 2005, Journal of molecular endocrinology.

[27]  D. Pasco,et al.  Evaluation of β-adrenergic receptor subtypes in the human prostate cancer cell line-LNCaP , 2003 .

[28]  G. Shakhar,et al.  Suppression of NK Cell Activity and of Resistance to Metastasis by Stress: A Role for Adrenal Catecholamines and β-Adrenoceptors , 2000, Neuroimmunomodulation.

[29]  G. Bodega,et al.  Expression of functional PACAP/VIP receptors in human prostate cancer and healthy tissue , 2003, Peptides.

[30]  A. Bookout,et al.  Targeting Gβγ Signaling to Inhibit Prostate Tumor Formation and Growth* , 2003, Journal of Biological Chemistry.

[31]  P. Poyet,et al.  Characteristics of the β‐adrenergic stimulation of adenylate cyclase activity in rat ventral prostate and its modulation by androgens , 1986, The Prostate.

[32]  H. Ruan,et al.  BAD Ser-155 Phosphorylation Regulates BAD/Bcl-XL Interaction and Cell Survival* , 2000, The Journal of Biological Chemistry.

[33]  L. Chung,et al.  Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. , 1994, Cancer research.

[34]  E. Gelmann,et al.  Androgen blocks apoptosis of hormone-dependent prostate cancer cells. , 2001, Cancer research.

[35]  A. Shaywitz,et al.  CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. , 1999, Annual review of biochemistry.

[36]  W. Zhang,et al.  PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. , 2000, Cancer research.

[37]  S. Gold,et al.  Higher Beck depression scores predict delayed epinephrine recovery after acute psychological stress independent of baseline levels of stress and mood , 2004, Biological Psychology.

[38]  L. Mazzolai,et al.  Blood sampling methodology is crucial for precise measurement of plasma catecholamines concentrations in mice , 2003, Pflügers Archiv.

[39]  S. Lutgendorf,et al.  Cancer fear and mood disturbance after radical prostatectomy: consequences of biochemical evidence of recurrence. , 2003, The Journal of urology.

[40]  J. Madden,et al.  Bradykinin receptor subtype 1 expression and function in prostate cancer. , 2003, Cancer research.

[41]  I. Bairati,et al.  Antihypertensive Drug Use and The Risk of Prostate Cancer (Canada) , 2004, Cancer Causes & Control.

[42]  G. Dent.  Protein kinase A‐independent responses to β‐adrenoceptor agonists , 2001 .

[43]  David Spiegel,et al.  Depression and cancer: mechanisms and disease progression , 2003, Biological Psychiatry.

[44]  S. Parsons,et al.  Interleukin-6- and Cyclic AMP-Mediated Signaling Potentiates Neuroendocrine Differentiation of LNCaP Prostate Tumor Cells , 2001, Molecular and Cellular Biology.

[45]  H. Frierson,et al.  Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate , 1997, Cancer.

[46]  V. Dixit,et al.  Characterization of Calcium Release-activated Apoptosis of LNCaP Prostate Cancer Cells* , 2000, The Journal of Biological Chemistry.

[47]  F. Révillion,et al.  Functionalβ-adrenergic receptors in breast cancer cells , 2005, Journal of Cancer Research and Clinical Oncology.

[48]  P. Cryer,et al.  Adrenomedullary response to maximal stress in humans. , 1984, The American journal of medicine.

[49]  M. Philipp,et al.  Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. , 2004, Pharmacology & therapeutics.

[50]  M. Milowsky,et al.  Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway. , 2001, Cancer research.